Thursday, June 04, 2009

Safety First!

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for June 2009 (PDF).

This issue contains stop press information about a potential interaction between clopidogrel and proton pump inhibitors, counterfeit NovoFine® needles and hepatitis risk from incorrect use of lancet devices. Drug safety advice covers the following areas:

  • Antipsychotics: risk of venous thromboembolic events
  • Chloral hydrate and Triclofos: not first-line options for insomnia
  • Oral salicylate gels: not for use in those younger than age 16 years
  • Topical ketoprofen: reminder on risk of photosensitivity reactions

No comments: